Mirtazapine in Alzheimer-associated Weight Loss

Mirtazapine in Alzheimer-associated Weight Loss: a Retrospective Phase IV Study

Weight loss is a frequent problem associated with Alzheimers disease (AD). Mirtazapine has weight loss as a frequent side effect.

The aim of this retrospective study is to check whether mirtazapine 30 mg (once daily) can counteract weight loss in patients with AD or mixed dementia (AD + vascular).

Inclusion Criteria:

• AD or mixed dementia
• documented weight loss
• mirtazapine 30 mg explicitly prescribed against weight loss

Exclusion Criteria:

• no treatment compliance
• other causes of weight loss
• other interventions against weight loss